New Therapies, Better Lives
Preserving muscle, enhancing metabolic health
Developing targeted approaches to maintain muscle mass and function during weight loss, ageing, and metabolic disease.
About Us
The Current Problem
Current approaches to weight loss and metabolic disease, including widely used GLP-1 therapies, can result in significan loss of skeltal muscle.
This loss reduces strength, physical function, and long-term metabolic health – potentially limitng the durability and overall benefit of treatment.
Despite rapid advances in obestiy therapeutics, there are no targeted solutions to preserve muscle during or after weight loss, representing a major unmet clinical and commerical need.
Services
Our Solution
SarcoNova are developing targeted interventions that preserve skeletal muscle mass and function during metabolic stress.
Our approach positions skeletal muscle as a central regulator of metabolic health – enabling patients to maintain:
- Strength
- Functional capacity
- Energy expenditure
Alongside improvements in body weight and glycaemic control.
Why It Matters
Sustaining Treatment Outcomes
Preserving skeletal muscle is essential to maintaining the long-term effectiveness of weight loss and metabolic therapies.
Supporting Healthy Ageing
Protecting muscle function helps maintain strength, independence, and resilience in ageing and at-risk populations.
Reducing Functional Decline
Preventing muscle loss reduces the risk of physical decline and supports overall metabolic health.
